-transparent.png){kind=logo}
The success rate of human embryo cryopreservation depends on technical and embryonic parameters. First of all, the cryoprotectant can affect embryo survival as we found by comparing two freeze-thaw procedures using propanediol (PROH) (1.5 mol) alone or with sucrose (0.1 mol). Embryo survival was significantly enhanced with sucrose (62 versus 32%). Embryo quality is another major parameter involved in the success of freezing; the rates of positive survival were found to be 67% for morphologically normal embryos versus 49% for embryos with fragments (P less than 0.001). The efficiency of embryo cryopreservation in an IVF programme could be estimated in 1986: a woman with extra embryos, stored after transfer of 3-4 fresh embryos (16% of all cycles), can expect a 22% pregnancy rate per transfer of fresh embryos and a 32% pregnancy rate per collection after transfer of the stored eggs. A comparative study of the cryopreservability of immature or mature oocytes was performed in humans. Human oocytes have a low survival rate (36%) whatever the cryopreservation protocol or the initial maturation stage. Immature human oocytes could survive freezing and thawing, mature and be fertilized in vitro, but with a very low efficiency.
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
June 1995,
Current opinion in obstetrics & gynecology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
January 2014,
Theriogenology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
October 1991,
Current opinion in obstetrics & gynecology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
January 2014,
BioMed research international,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
January 2004,
Methods in molecular biology (Clifton, N.J.),
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
October 1992,
Current opinion in obstetrics & gynecology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
October 1993,
Current opinion in obstetrics & gynecology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
January 1996,
Biotechnology advances,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
January 2006,
Theriogenology,
J Mandelbaum, and
A M Junca, and
M Plachot, and
M O Alnot, and
J Salat-Baroux, and
S Alvarez, and
C Tibi, and
J Cohen, and
C Debache, and
L Tesquier
March 2009,
Journal of visualized experiments : JoVE,
